LIXT

Lixte Biotechnology Holdings Inc

NASDAQ: LIXT · HEALTHCARE · BIOTECHNOLOGY

$7.21

-6.00% today

Updated 2026-07-02

Market cap

$133.35M

P/E ratio

—

P/S ratio

20.35x

EPS (TTM)

$-1.15

Dividend yield

—

52W range

$2 – $8

Volume

0.3M

Market cap

$133.35M

P/E ratio

—

P/S ratio

20.35x

EPS (TTM)

$-1.15

Dividend yield

—

52W range

$2 – $8

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.8

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →270 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.13x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.86M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-6.31M	$-5.09M	$-3.59M	$-6.01M	$-1.92M
EPS	—	—	—	—	$-1.15
Free cash flow	$-4.61M	$-4.29M	$-3.16M	$-3.07M	$-1.86M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LIXT	$133.35M	16	4.3	3.0	5.0	6.8	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

Lixte Biotechnology Holdings Inc trades at $7.21. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Lixte Biotechnology Holdings Inc's stock price?

Lixte Biotechnology Holdings Inc (LIXT) trades at $7.21, on a P/S of 20.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Lixte Biotechnology Holdings Inc overvalued?

Lixte Biotechnology Holdings Inc carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio20.35x

ROE-102.00%

Beta1.28

50D MA$5.75

200D MA$4.30

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LIXT vs LLY →LIXT vs JNJ →LIXT vs ABBV →Stock screener →